alendronate has been researched along with Erythema in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate is a bisphosphonate compound used to treat diseases of pathologic bone resorption." | 5.32 | Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis. ( Cockerell, CJ; Cohen, JB; High, WA; Wetherington, W, 2003) |
| "Alendronate is a bisphosphonate compound used to treat diseases of pathologic bone resorption." | 1.32 | Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis. ( Cockerell, CJ; Cohen, JB; High, WA; Wetherington, W, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Villanueva-MartÃnez, A | 1 |
| Hernández-Rizo, L | 1 |
| Ganem-Rondero, A | 1 |
| High, WA | 1 |
| Cohen, JB | 1 |
| Wetherington, W | 1 |
| Cockerell, CJ | 1 |
2 other studies available for alendronate and Erythema
| Article | Year |
|---|---|
Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate.
Topics: Administration, Cutaneous; Alendronate; Animals; Bone Density Conservation Agents; Drug Carriers; Dr | 2020 |
Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis.
Topics: Aged; Alendronate; Erythema; Female; Humans; Osteoporosis | 2003 |